Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Questions

Questions

posted on Jan 16, 2008 09:08AM

1. What is PTSC's policy for communicating with shareholders?

The monthly letter to shareholders is long overdue. Why?

Why no pr with the recent 10Q?

Are you aware of any share price manipulation, and if you are what do you attribute it to?

Shareholders would like to know that we have a voice. Can Brian Biajj take a more active role in being our shareholder representative by allowing him to post on Agoracom updates approved through the BOD? Also as our contact to deliver questions and concerns to the BOD and post what he can?

Where does PTSC see itself in the next year, 2 years, 5 years? Is PTSC on target for accomplishing it's goals of M&A, Licensing, and getting off the OTCBB?

Share
New Message
Please login to post a reply